1
Christopher Schuler, Edward Schuler: Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency. BIO Cat, Hunton & Williams, December 6, 2011: US08071089 (3 worldwide citation)

The invention provides compositions and methods for treating pancreatic enzyme insufficiency, such as the pancreatic enzyme insufficiency associated with cystic fibrosis. The invention also provides compositions comprising lipase from Candida cylindracea, alone or in combination with amylase or amyl ...


2
Schuler Christopher, Schuler Edward F: (yeast) Lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency. Bio Cat, Schuler Christopher, Schuler Edward F, POSORSKE Laurence H, May 10, 2007: WO/2007/053619 (1 worldwide citation)

The invention provides compositions and methods for treating pancreatic enzyme insufficiency, such as the pancreatic enzyme insufficiency associated with cystic fibrosis. The invention also provides compositions comprising lipase from Candida cylindracea, alone or in combination with amylase or amyl ...


3
Christopher Schuler, Edward Schuler, Christopher S Penet, Kelly Gregory, K Gregory Moore: Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase. BIO CAT, Hunton & Williams, January 31, 2017: US09555083

The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of ...


4
Christopher Schuler, Edward Schuler, Christopher S Penet, Gregory Moore, Kelly Gregory: Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase. Bio Cat, Hunton & Williams, September 18, 2012: US08268305

The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of ...


5
Jessica Spears, Steve C Lamb, Sebhat Gebrechristos, Christopher Schuler: strains and methods of use to suppress the activities and growth of fungal plant pathogens, Compositions comprising. BIO CAT MICROBIALS, Arent Fox, December 18, 2018: US10154670

This invention provides compositions of Bacillus strains and methods for using such compositions to inhibit the activity and/or growth of fungal pathogens of plants. In one embodiment, this invention provides a composition comprising Bacillus bacteria selected from the group consisting of Brevibacil ...


6
MOORE Kenneth Gregory, SCHULER Christopher, SCHULER Edward, PENET Christopher S, GREGORY Kelly: [fr] MÉTHODES ET COMPOSITIONS PERMETTANT DABAISSER LE TAUX SÉRIQUE DE TRIGLYCÉRIDES CHEZ LÊTRE HUMAIN AU MOYEN DUNE LIPASE FONGIQUE, [en] METHODS AND COMPOSITIONS TO REDUCE SERUM LEVELS OF TRIACYLGLYCERIDES IN HUMAN BEINGS USING A FUNGAL LIPASE. MOORE Kenneth Gregory, BIO CAT, POSORSKE Laurence H, March 28, 2013: WO/2013/043587

[en] The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum leve ...


7
METHODS AND COMPOSITIONS TO REDUCE SERUM LEVELS OF TRIACYLGLYCERIDES IN HUMAN BEINGS USING A FUNGAL LIPASE. BIO CAT, October 2, 2014: US20140294802-A1

The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of ...


8
Compositions Comprising Bacillus Strains and Methods of Use to Suppress the Activities and Growth of Fungal Plant Pathogens. BIO CAT MICROBIALS, July 7, 2016: US20160192660-A1

This invention provides compositions of Bacillus strains and methods for using such compositions to inhibit the activity and/or growth of fungal pathogens of plants. In one embodiment, this invention provides a composition comprising Bacillus bacteria selected from the group consisting of Brevibacil ...


9